Clinical Trials

Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 10 of 122 Clinical Trials Related to Cancer

Mirati-EAP-001

Expanded Access of Adagrasib (MRTX849) in Patients with Advanced Solid Tumors Who Have a KRAS G12C Mutation

Doctor(s) Running This Study

Mirati-EAP-001

Expanded Access of Adagrasib (MRTX849) in Patients with Advanced Solid Tumors Who Have a KRAS G12C Mutation

Doctor(s) Running This Study

A031704 Renal Cell Cancer

PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]

Doctor(s) Running This Study

Strata STR-005-001 Genomic Study

A Prospective Study Evaluating Combined Comprehensive Genomic And Transcriptomic Profiling With Ctdna Testing For Recurrence Detection And Treatment Monitoring Of Patients With Solid Tumors

Doctor(s) Running This Study

NRG BN007

A Randomized Phase II/III Open-label Study of Ipilimumab and Nivolumab vs Temozolomide in Patients with Newly Diagnosed MGMT Unmethylated Glioblastoma

Doctor(s) Running This Study

A011801 Breast Cancer

THE COMPASSHER2 TRIALS (COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2-POSITIVE BREAST CANCER): COMPASSHER2 RESIDUAL DISEASE (RD), A DOUBLE-BLINDED, PHASE III RANDOMIZED TRIAL OF T-DM1 AND PLACEBO

Doctor(s) Running This Study

Swog 1826 Hodgkin Lymphoma

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Doctor(s) Running This Study